Monthly Archives: May 2016

Riding The Gene Editing Wave: Reflections On CRISPR/Cas9’s Impressive Trajectory
May 31, 2016

CRISPR/Cas genome editing has captured the attention of the popular media, scientific community, and the investment world: the promise of going into a cell and precisely making changes in their genetic code to cure them of illness is certainly captivating.


Our Experience With First-Time Biotech CEOs: Five Behaviors That Matter
May 25, 2016

Jumping into a first-time CEO role in an emerging biotech is a daunting but exciting opportunity – both for the newly-minted chief executive and their Board of Directors. A great hire can be positively catalytic to a startup; and, sadly,


Of Mice And Men: Translation In Psychiatric Disease
May 12, 2016

This blog was written by Vanessa King, CEO of Luc Therapeutics, as part of the From The Trenches feature of LifeSciVC Almost 15 years ago – in 2003, to be precise – I was working with genome sequencing pioneer Craig


A Tale of Two Startup Worlds: Biotech And Tech VC Ecosystems
May 9, 2016

Startup ecosystems supported by venture capital are defined by dynamism, with the creation, growth, exiting, or failure of new innovative companies conspiring to keep these entrepreneurial landscapes in constant change. Investor returns and sentiment are dramatically impacted by how these


Riding Dancing Unicorns Down The Road To Recap
May 2, 2016

This post was written by Michael Gladstone, Principal at Atlas Venture, as part of the From The Trenches feature of LifeSciVC. Ex-Citigroup CEO Charles Prince famously said in July 2007, regarding Citi’s leveraged lending business, “As long as the music

Leave a comment